NSEReply to Clarification- Financial results25 Jun 2026 · 25 Jun 2026, 07:33 pm

Reply to Clarification- Financial results

Vivimed Labs Limited · VIVIMEDLAB

✦ AI SummaryResults

Vivimed Labs Limited has responded to the National Stock Exchange's (NSE) clarification request regarding its financial results for the quarter ended March 31, 2025. The company clarified that the financial results were not submitted in the prescribed format, and there were technical issues with scanning and filing the documents, resulting in a delay in uploading the results.

Analysis Scores

Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk2/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

The Exchange had sought clarification from Vivimed Labs Limited for the quarter ended 31-Mar-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: The response of the Company is enclosed.

Attachments (1)

📄

VIVIMEDLAB_17092025145312_Clarification_letter.pdf

pdf

Download →
View document text
Date: 19.07.2025 To Vivimed National Stock Exchange of India Ltd. Exchange Plaza,Plot no. Cl1, G Block, Bandra-Kurla Complex, Bandra (E) Mumbai -400 051 NSE- Symbol: VlVIMEDLAB Dear Sir I Madam, Sub: Clarification for Financial results-VIVIMEDLAB for PeriodlYear ended March 31,2025. Ref: Your mail dated 30 June 2025 With reference to above, we hereby clarifY as under: 1. Financial results submitted is not as per format prescribed by SEBI_M D/CEO sign missing in Statement on Impact of audit qualifications. . Ans: Statement on Impact of audit qualifications signed by Mr.Manohar Rao Varalwar, Whole Time Director (KMP) (Managing Director is not present at the meeting) (Board Authorised Mr.Manohar Rao Varalwar for signing the same) .. 2. Financial results not submitted within 30 minutes or 3 hours from the end of board meeting (as may be applicable) Ans: We would like to inform you that there is a scanneF problem (technical issue) in scanning the documents. Hence there is a delay in filing Financial Results for the quarter & year ending 2025. Meeting concluded at 22.10 PM on 30.05.2025 and upload happened on 31.05.2025 at 12:13:38 PM (It happened with in 3 hours from the end of the meeting and approximately 14 minutes delay). 3. Financial results submitted in XBRL with discrepancies Ans: We tried to file Revised XBRL Financial results FY25 and while filing error is coming, hence we sent an email tolistingfr@nse.co.in on 02.07.2025, reply not yet received from NSE. We will take care for technical issues (like printer and scanner) in future. This is for your information and records. Thanking you, Yours faithfully, For Vivimed Labs Ltd Kopparthi Yugandhar Company Secretary Corporate Office: :.,abs Lirr1ited \3,,3,,86GilfG1. 3'" Floor, CMf{ Tower::" (Jreenlands, Begurnpet, Hyderabmj, Olliee: #'78/A, [<Gihar Industrial Area Telangana - tiOO 0'16, India. Bidar, f\nrnatakfJ " G3G 40'3, India, GST!N: :Y)AAACVGD60A 170 l ·~<rl {O) a4H2 .. 2:j.2G45. F +9'1 (0) g;~·~12··2~32436 T +S1(O) 40,6(303,,6GOI:\. F +01(0) 40 6601:\·GG!JS Email: lwww.vivimedlabs.com